𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I clinical and pharmacokinetic study of the oral and the oral/ intravenous administration of menogaril

✍ Scribed by Geoffrey R. Weiss; Thomas D. Brown; John G. Kuhn; Daniel D. Hoff; Robert H. Earhart; Wade J. Adams; J. E. Brewer; J. D. Hosley; Dorothy A. Kasunic

Publisher
Springer US
Year
1993
Tongue
English
Weight
742 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I trial and pharmacokinetic study
Phase I trial and pharmacokinetic study of intravenous and oralΞ±-Difluoromethylornithine
✍ Constance A. Griffin; Milan Slavik; Shu Chean Chien; Joachim Hermann; George Tho πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 617 KB

Eflornithine-HCl (alpha-difluoromethylornithine or DFMO), an irreversible inhibitor of ornithine decarboxylase, blocks polyamine synthesis and has demonstrated antitumor activity in cell culture and animal tumor models. This phase I study was designed to determine and compare toxicity and the maxima

Pharmacokinetics of ethopropazine in the
Pharmacokinetics of ethopropazine in the rat after oral and intravenous administration
✍ Mojdeh Maboudian-Esfahani; Dion R. Brocks πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

The pharmacokinetics of the anticholinergic drug ethopropazine (ET) have been studied in the rat after intravenous (i.v.) and oral administration. After i.v. doses of 5 and 10 mg/kg ET HCl, mean +/- S.D. plasma AUC were 9836 +/- 2129 (n = 4 rats) and 13096 +/- 4186 ng h/mL (n = 5 rats), respectively